Familial Chylomicronemia (Type I Hyperlipoproteinemia) Pipeline Insight Report 2019 Featuring Aegerion, Catabasis, CymaBay, Kadmon, & Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Apr 9, 2019--The "Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com'…
